Medivir (MVIR.ST)
Quick facts
| Ticker | MVIR.ST (Nasdaq Stockholm) |
|---|
Phase 3 pipeline
- acyclovir in ME-609 vehicle · Infectious Diseases
Acyclovir is an antiviral medication that inhibits viral DNA synthesis by inhibiting viral DNA polymerase. - ME-609 · Virology/Infectious Disease
ME-609 is a hepatitis C virus (HCV) NS5B polymerase inhibitor that blocks viral RNA replication.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: